GRPR and breast carcinoma: Human breast cancer, for example, overexpresses in about 75% of all cases the gastrin-releasing peptide receptor (GRPR) [7] and in 66–85% the neuropeptide Y receptor subtype 1 (NPY(Y1)R) [8].